These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15823076)

  • 21. Renal safety of gadolinium-based contrast agent for ionizing radiation imaging.
    Becker J; Thompson H
    Radiology; 2006 Jul; 240(1):301-2; author reply 302. PubMed ID: 16793989
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct; 17(97):205. PubMed ID: 19537311
    [No Abstract]   [Full Text] [Related]  

  • 23. Potential for misinterpretation of combined T1- and T2-weighted contrast-enhanced MR imaging of cartilage.
    Burstein D; Williams A; McKenzie C; Woertler K; Rummeny EJ
    Radiology; 2004 Nov; 233(2):619-20; author reply 621-2. PubMed ID: 15516627
    [No Abstract]   [Full Text] [Related]  

  • 24. A follow-up of four cases of nephrogenic systemic fibrosis: is gadolinium the specific trigger?
    Singh M; Davenport A; Clatworthy I; Lewin J; Deroide F; Hubbard V; Rustin MH
    Br J Dermatol; 2008 Jun; 158(6):1358-62. PubMed ID: 18363754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
    Stratta P; Canavese C; Quaglia M; Fenoglio R
    Rheumatology (Oxford); 2010 Apr; 49(4):821-3. PubMed ID: 20032228
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
    Kane GC; Stanson AW; Kalnicka D; Rosenthal DW; Lee CU; Textor SC; Garovic VD
    Nephrol Dial Transplant; 2008 Apr; 23(4):1233-40. PubMed ID: 18256017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid deterioration of renal insufficiency after magnetic resonance imaging with gadolinium-based contrast agent.
    Fujisaki K; Ono-Fujisaki A; Kura-Nakamura N; Komune N; Hirakawa N; Tsuruya K; Komune S; Iida M
    Clin Nephrol; 2011 Mar; 75(3):251-4. PubMed ID: 21329636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac arrest caused by IV gadopentetate dimeglumine.
    Unal O; Arslan H
    AJR Am J Roentgenol; 1999 Apr; 172(4):1141. PubMed ID: 10587169
    [No Abstract]   [Full Text] [Related]  

  • 29. Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor.
    Moreno-Romero JA; Segura S; Mascaró JM; Cowper SE; Julià M; Poch E; Botey A; Herrero C
    Br J Dermatol; 2007 Oct; 157(4):783-7. PubMed ID: 17627792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver.
    Yamamoto A; Tamada T; Sone T; Higashi H; Yamashita T; Ito K
    J Comput Assist Tomogr; 2010; 34(6):868-73. PubMed ID: 21084902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
    Bennett LK; Garrett AL
    Cutis; 2008 May; 81(5):421-6. PubMed ID: 18543594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous treatment.
    Spinosa DJ; Matsumoto AH; Angle JF; Hagspiel KD; McGraw JK; Ayers C
    Radiology; 1999 Mar; 210(3):663-72. PubMed ID: 10207465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The need for radiologists' awareness of nephrogenic systemic fibrosis.
    Aydingöz U
    Diagn Interv Radiol; 2006 Dec; 12(4):161-2. PubMed ID: 17160795
    [No Abstract]   [Full Text] [Related]  

  • 34. Gadolinium and kidney disease: are your patients at risk?
    Hollister D
    Nephrol Nurs J; 2008; 35(2):196-7. PubMed ID: 18472687
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute allergic reaction upon first exposure to gadolinium-DTPA: a case report.
    Rahman SL; Harbinson MT; Mohiaddin R; Pennell DJ
    J Cardiovasc Magn Reson; 2005; 7(5):849-51. PubMed ID: 16353448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients.
    Remy-Jardin M; Bahepar J; Lafitte JJ; Dequiedt P; Ertzbischoff O; Bruzzi J; Delannoy-Deken V; Duhamel A; Remy J
    Radiology; 2006 Mar; 238(3):1022-35. PubMed ID: 16505397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?
    Thomsen HS; Morcos SK; Dawson P
    Clin Radiol; 2006 Nov; 61(11):905-6. PubMed ID: 17018301
    [No Abstract]   [Full Text] [Related]  

  • 38. Gadodiamide administration causes spurious hypocalcemia.
    Prince MR; Erel HE; Lent RW; Blumenfeld J; Kent KC; Bush HL; Wang Y
    Radiology; 2003 Jun; 227(3):639-46. PubMed ID: 12773671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morbidity of direct MR arthrography.
    Hall FM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1524. PubMed ID: 22109312
    [No Abstract]   [Full Text] [Related]  

  • 40. [What are the remaining indications for gadolinium contrast in CT].
    Clément O
    J Radiol; 2009 Mar; 90(3 Pt 1):261. PubMed ID: 19421108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.